Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Miglitol

Trial Locations (13)

Unknown

Aichi

Chiba

Fukuoka

Gifu

Gunma

Hokkaido

Ibaraki

Kanagawa

Kumamoto

Miyazaki

Osaka

Saitama

Tochigi

All Listed Sponsors
lead

Sanwa Kagaku Kenkyusho Co., Ltd.

INDUSTRY

NCT00334399 - Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide | Biotech Hunter | Biotech Hunter